Disposable scope could cut infection risk in ERCP

NCT ID NCT05225909

Completed Knowledge-focused Sponsor: Nottingham University Hospitals NHS Trust Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new single-use duodenoscope (aScope) in 59 patients at high risk of infection after ERCP, a procedure to treat bile duct problems. The goal was to see if the scope works well and to gather information on costs and complications. The results could help decide if single-use scopes are a good option to prevent infections from contaminated reusable scopes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: single-use duodenoscope (aScope)
What this could lead to: If successful, this could show that single-use scopes are a safe and effective option to reduce infection risk after ERCP.
What could go wrong: This is a small, observational study with only 59 participants, so results may not apply to all patients. It does not directly compare infection rates with reusable scopes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHOLANGITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cholangitis Infections infectious disease primary sclerosing cholangitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHOLANGITIS ERCP INFECTION

Contacts and locations

Locations

Nottingham University Hospitals NHS Trust

Nottingham, Nottingham, Ng7 2UH, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.